CHARMHEE LEE: Open Payments
NPI 1932435971 · MERCHANTVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 28 payments from 9 companies in 2025. Trend: 2023 $175 · 2024 $198 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $149 |
| AstraZeneca Pharmaceuticals LP | 6 | $100 |
| Exact Sciences Corporation | 3 | $78 |
| Lilly USA, LLC | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| Amgen Inc. | 2 | $34 |
| Astellas Pharma US Inc | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| ABBVIE INC. | 1 | $16 |
Products named: FARXIGA, Cologuard Collection Kit, MOUNJARO, Wegovy, Ozempic, REXULTI, Rybelsus, OTEZLA.
Industry payments across NJ — which companies pay providers there.
